Cargando…

1596P SERONCOVID: Seroconversion in solid-tumor cancer patients (p) after COVID-19 diagnosis

Detalles Bibliográficos
Autores principales: Pous, A., Felip, E., Ulazia, O. Etxaniz, Hernández, A., España, S., Marin, M. Romeo, Moran, T., Molina, J.G., Fernandez, G., Pinato, D.J., Esteve, A.M., Mesía, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454301/
http://dx.doi.org/10.1016/j.annonc.2021.08.1589
_version_ 1784570456707170304
author Pous, A.
Felip, E.
Ulazia, O. Etxaniz
Hernández, A.
España, S.
Marin, M. Romeo
Moran, T.
Molina, J.G.
Fernandez, G.
Pinato, D.J.
Esteve, A.M.
Mesía, R.
author_facet Pous, A.
Felip, E.
Ulazia, O. Etxaniz
Hernández, A.
España, S.
Marin, M. Romeo
Moran, T.
Molina, J.G.
Fernandez, G.
Pinato, D.J.
Esteve, A.M.
Mesía, R.
author_sort Pous, A.
collection PubMed
description
format Online
Article
Text
id pubmed-8454301
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Society for Medical Oncology. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-84543012021-09-21 1596P SERONCOVID: Seroconversion in solid-tumor cancer patients (p) after COVID-19 diagnosis Pous, A. Felip, E. Ulazia, O. Etxaniz Hernández, A. España, S. Marin, M. Romeo Moran, T. Molina, J.G. Fernandez, G. Pinato, D.J. Esteve, A.M. Mesía, R. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2021-09 2021-09-21 /pmc/articles/PMC8454301/ http://dx.doi.org/10.1016/j.annonc.2021.08.1589 Text en Copyright © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Pous, A.
Felip, E.
Ulazia, O. Etxaniz
Hernández, A.
España, S.
Marin, M. Romeo
Moran, T.
Molina, J.G.
Fernandez, G.
Pinato, D.J.
Esteve, A.M.
Mesía, R.
1596P SERONCOVID: Seroconversion in solid-tumor cancer patients (p) after COVID-19 diagnosis
title 1596P SERONCOVID: Seroconversion in solid-tumor cancer patients (p) after COVID-19 diagnosis
title_full 1596P SERONCOVID: Seroconversion in solid-tumor cancer patients (p) after COVID-19 diagnosis
title_fullStr 1596P SERONCOVID: Seroconversion in solid-tumor cancer patients (p) after COVID-19 diagnosis
title_full_unstemmed 1596P SERONCOVID: Seroconversion in solid-tumor cancer patients (p) after COVID-19 diagnosis
title_short 1596P SERONCOVID: Seroconversion in solid-tumor cancer patients (p) after COVID-19 diagnosis
title_sort 1596p seroncovid: seroconversion in solid-tumor cancer patients (p) after covid-19 diagnosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454301/
http://dx.doi.org/10.1016/j.annonc.2021.08.1589
work_keys_str_mv AT pousa 1596pseroncovidseroconversioninsolidtumorcancerpatientspaftercovid19diagnosis
AT felipe 1596pseroncovidseroconversioninsolidtumorcancerpatientspaftercovid19diagnosis
AT ulaziaoetxaniz 1596pseroncovidseroconversioninsolidtumorcancerpatientspaftercovid19diagnosis
AT hernandeza 1596pseroncovidseroconversioninsolidtumorcancerpatientspaftercovid19diagnosis
AT espanas 1596pseroncovidseroconversioninsolidtumorcancerpatientspaftercovid19diagnosis
AT marinmromeo 1596pseroncovidseroconversioninsolidtumorcancerpatientspaftercovid19diagnosis
AT morant 1596pseroncovidseroconversioninsolidtumorcancerpatientspaftercovid19diagnosis
AT molinajg 1596pseroncovidseroconversioninsolidtumorcancerpatientspaftercovid19diagnosis
AT fernandezg 1596pseroncovidseroconversioninsolidtumorcancerpatientspaftercovid19diagnosis
AT pinatodj 1596pseroncovidseroconversioninsolidtumorcancerpatientspaftercovid19diagnosis
AT esteveam 1596pseroncovidseroconversioninsolidtumorcancerpatientspaftercovid19diagnosis
AT mesiar 1596pseroncovidseroconversioninsolidtumorcancerpatientspaftercovid19diagnosis